News | UM Greenebaum Comprehensive Cancer Center

Welcome to the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center Newsroom. In this section, you can find the latest news releases, media team contact information and additional resources for journalists.

Contact the Media Team

During Business Hours: Call 410-328-8919 or email media@umm.edu
After Business Hours: Email media@umm.edu (monitored every day, 24/7). This is the quickest way to reach a member of the media relations staff. Urgent messages will receive immediate attention.

Showing 1-10 of 50

In First-of-Its-Kind Surgery, Rare Spinal Tumor Removed Through Patient’s Eye Socket at University of Maryland Medical Center

May 05, 2025

In a first-of-its-kind surgery, a team led by a University of Maryland Medical Center (UMMC) neurosurgeon has successfully removed a rare cancerous tumor wrapped around the spine and spinal cord of a 19-year-old woman – through her eye socket (orbit).

Researchers Identify “Master Regulator” Gene That Could Lead To More Effective Treatment For Patients With Ovarian Cancer

April 03, 2025

In a study co-led by the University of Maryland School of Medicine (UMSOM), researchers have identified a “master regulator” gene, ZNFX1, that may act as a biomarker to help guide treatment in future clinical trials involving patients with therapy-resistant ovarian cancer, according to a study recently published in Cancer Research.

Innovative CT Scan Technique Could Improve Prognosis and Treatments for Head and Neck Cancers, New Research Suggests

February 26, 2025

Cancers occurring in the mouth, nose, and throat are on the rise in the U.S., especially in younger people. About 60,000 new cases are diagnosed every year with one in five cases occurring in people younger than 55, according to the American Cancer Society. A new study provides insights that may eventually help oncologists better predict how the disease will respond to certain therapies, leading to improved survival outcomes for patients.

Jeremy L. Davis, MD, Named UMGCCC Surgical Oncology Lead and Chief of the Division of Surgical Oncology at UMSOM

January 15, 2025

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) Executive Director, Taofeek K. Owonikoko, MD, PhD, and University of Maryland School of Medicine (UMSOM) Department of Surgery Chair, Christine Lau, MD, MBA, have announced that Jeremy L. Davis, MD, has been appointed the new Surgical Oncology Lead for UMGCCC and Chief of the Division of Surgical Oncology in the Department of Surgery at UMSOM. Dr. Davis is a nationally recognized surgical oncologist and leader in gastric cancer research. He started in his new roles at the end of last month.

University of Maryland Greenebaum Comprehensive Cancer Center Offers Novel Next-Generation CAR T-cell Therapy for B-cell Lymphomas in First-in-Human Clinical Trial

November 25, 2024

Researchers at the University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC) are conducting a first-in-human clinical trial of a novel next-generation CAR T-cell therapy to treat patients with recurrent or difficult-to-treat B-cell lymphomas, which are cancers of the lymphatic system.

Early Results from Multiple Myeloma Clinical Trial Prove Cancer Drug Combination Provides Longer Response and Potential Benefit in Disease-Free Survival

October 02, 2024

Patients with multiple myeloma, a type of cancer in their white blood cells, have a significantly longer disease-free period and likely long-term survival if they are treated with the monoclonal antibody drug daratumumab along with the standard therapy drug lenalidomide compared to the standard therapy alone.

Cancer Patients Who Experience Cognitive Decline After Radiation Treatment for Brain Metastases May Regain Full Neurocognitive Function, New Study Suggests

October 01, 2024

Nearly 40 percent of cancer patients who experienced memory loss, brain fog and other cognitive difficulties after radiation treatment for brain metastases regained full neurocognitive function within six months, according to a new analysis by radiation oncology researchers at the University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC).

Three University of Maryland Medical System Hospitals Ranked Among Top Five In Maryland

July 16, 2024

Three University of Maryland Medical System (UMMS) hospitals – the University of Maryland Medical Center (Downtown Campus), UM St. Joseph Medical Center in Towson (Baltimore County) and UM Baltimore Washington Medical Center in Glen Burnie (Anne Arundel County) – rank among the top five hospitals in the Baltimore region and the state, according to U.S. News & World Report's 2024 Best Hospitals, released today.

Study: Living in Disadvantaged Neighborhoods Influences Stress-Related Genes, Which May Contribute to Aggressive Prostate Cancer in African American Men

July 12, 2024

Those living in disadvantaged neighborhoods have significantly higher activity of stress-related genes, new research suggests, which could contribute to higher rates of aggressive prostate cancer in African American men. The study, which was co-led by the University of Maryland School of Medicine (UMSOM) and Virginia Commonwealth University (VCU), was published today in JAMA Network Open.

University of Maryland Greenebaum Comprehensive Cancer Center and AstraZeneca Partner to Enhance Community Based Lung Cancer Screening and Detection for Marylanders at High Risk

April 16, 2024

With only a small percentage of Marylanders at high risk for lung cancer getting the recommended annual screening, the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) today launched a new statewide effort to increase annual screenings.

Showing 1-10 of 50

Results per Page